Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Revolution Medicines (RVMD) Times Interest Earned (2019 - 2025)

Revolution Medicines has reported Times Interest Earned over the past 5 years, most recently at -$47.57 for Q4 2025.

  • Quarterly results put Times Interest Earned at -$47.57 for Q4 2025, up 44.4% from a year ago — trailing twelve months through Dec 2025 was $286.23 (up 321.55% YoY), and the annual figure for FY2025 was -$6420.9, down 2254.09%.
  • Times Interest Earned for Q4 2025 was -$47.57 at Revolution Medicines, down from -$27.59 in the prior quarter.
  • Over the last five years, Times Interest Earned for RVMD hit a ceiling of -$27.59 in Q3 2025 and a floor of -$3116.4 in Q1 2021.
  • Median Times Interest Earned over the past 3 years was -$50.15 (2024), compared with a mean of -$665.46.
  • Biggest five-year swings in Times Interest Earned: tumbled 210.43% in 2021 and later skyrocketed 44.4% in 2025.
  • Revolution Medicines' Times Interest Earned stood at -$3116.4 in 2021, then skyrocketed by 97.25% to -$85.57 in 2024, then skyrocketed by 44.4% to -$47.57 in 2025.
  • The last three reported values for Times Interest Earned were -$47.57 (Q4 2025), -$27.59 (Q3 2025), and -$85.57 (Q4 2024) per Business Quant data.